New Delhi/Washington: The US, which recently downgraded the DGCA’s safety ratings, is expected to announce traderelated measures in what is seen as a retaliatory move against India’s recent stand on the patent regime.
The US Trade Representative announcement will come aday after the US Chamber filed a submission to the USTR on the Special 301 Report. The Special 301 Report is an annual report on the adequacy and protection of intellectual property in various countries.
Drug MNCs have been lobbying with Washington for retaliatory action against India over the special provisions in the patents law that require the patent holder to prove a genuine invention has been made and the matter in question is not a mere upgradation of an existing product. P 15
TIT FOR TAT?
US set to announce traderelated measures against India
The move has been prompted by drug majors pushing for retaliatory action over India’s patent regime
Citing local norms, India has denied rights to some medicines that US firms had sought patents for
The development comes within days of US downgrading DGCA’s safety ratings and the Devyani Khobragade row  |
|
No comments:
Post a Comment